Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin

被引:33
作者
García-Arata, MI
Baquero, F
de Rafael, L
de Argila, CM
Gisbert, JP
Bermejo, F
Boixeda, D
Cantón, R
机构
[1] Hosp Ramon & Cajal, Dept Microbiol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Dept Gastroenterol, E-28034 Madrid, Spain
关键词
D O I
10.1128/AAC.43.2.374
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mutations conferring resistance to erythromycin or clarithromycin in Helicobacter pylori were studied. Mutation A2142G was consistently associated with clarithromycin MIC of >256 mu g/ml, whereas mutants carrying A2143G had MICs ranging from less than or equal to 0.016 to >256 mu g/ml, suggesting that additional factors account for the observed multiple levels of resistance to clarithromycin.
引用
收藏
页码:374 / 376
页数:3
相关论文
共 21 条
[1]  
BLASER MJ, 1997, HELICOBACTER PYLORI
[2]  
DEBETSOSSENKOPP YJ, 1997, 3M INT C ANT AG CHEM, P69
[3]  
GLUPCZYNSKI Y, 1992, EUR J CLIN MICROBIOL, V11, P777
[4]   EVALUATION OF THE E-TEST FOR QUANTITATIVE ANTIMICROBIAL SUSCEPTIBILITY TESTING OF HELICOBACTER-PYLORI [J].
GLUPCZYNSKI, Y ;
LABBE, M ;
HANSEN, W ;
CROKAERT, F ;
YOURASSOWSKY, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :2072-2075
[5]  
Graham DY, 1996, AM J GASTROENTEROL, V91, P1072
[6]  
Hsieh PF, 1998, J FORMOS MED ASSOC, V97, P445
[7]   Macrolide resistance in Helicobacter pylori: Mechanism and stability in strains from clarithromycin-treated patients [J].
Hulten, K ;
Gibreel, A ;
Skold, O ;
Engstrand, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2550-2553
[8]  
Malfertheiner P, 1997, GUT, V41, P8
[9]   Clarithromycin and omeprazole - As Helicobacter pylori eradication therapy in patients with H-pylori associated gastric disorders [J].
Markham, A ;
McTavish, D .
DRUGS, 1996, 51 (01) :161-178
[10]  
NEU HC, 1991, J ANTIMICROB CHEMOTH, V27, P1